Michael Soulen on Radioembolization of Neuroendocrine Tumor Liver Metastases

Article

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.

Radioembolization, which has been used since the early 2000s, injects microscopic radioactive seeds into the bloodstream. The seeds lodge themselves into the tumor and emit radiation over a couple of weeks as they decay.

Embolization is particularly effective for NETs, Soulen says, with a high response rate and only about 5% of patients reporting significant complications from the therapy.

The treatment is also effective in recurrent cases because the tumors do not become resistant, but instead grow a new blood supply that can be cut off again.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Related Content